Cleared Traditional

K935868 - DYNAPHOR(TM) TWO

K935868 is an FDA 510(k) clearance for DYNAPHOR(TM) TWO, manufactured by Maxxim Medical. The device is a Class 2 Physical Medicine device with product code EGJ cleared through the Traditional 510(k) pathway after a 464-day FDA review.

K935868 · Maxxim Medical · Physical Medicine device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1995
Decision
464d
Days
Class 2
Risk

K935868 is an FDA 510(k) clearance for the DYNAPHOR(TM) TWO. Classified as Device, Iontophoresis, Other Uses (product code EGJ), Class II - Special Controls.

Submitted by Maxxim Medical (Sugar Land, US). The FDA issued a Cleared decision on March 15, 1995 after a review of 464 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Physical Medicine FDA review panel, regulated under 21 CFR 890.5525 - the FDA physical medicine device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Physical Medicine submissions.

View all Maxxim Medical devices

FDA 510(k) Submission Details - K935868

510(k) Number K935868 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 06, 1993
Decision Date March 15, 1995
Days to Decision 464 days
Submission Type Traditional
Review Panel Physical Medicine (PM)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
348d slower than avg
Panel avg: 116d · This submission: 464d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

EGJ Device Classification - Class 2, Special Controls

Product Code EGJ Device, Iontophoresis, Other Uses
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 890.5525
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Physical Medicine devices follow this clearance model.

Regulatory Peers - EGJ Device, Iontophoresis, Other Uses

All 60
Devices cleared under the same product code (EGJ) and FDA review panel - the closest regulatory comparables to K935868.
DUPEL II BUFFERED IONTOPHORESIS ELECTRODES
K970491 · Empi · May 1997
MD-1A GALVANIC UNIT
K964208 · R. A. Fischer Co. Corp. · Apr 1997
IT-727 (ALSO KNOWN AS IT-610, IT-600 AND DYNAPHOR II
K946337 · Skylark Device Co., Ltd. · Dec 1995
RH-806/GS MODEL TRANSQ(R)2
K932620 · Iomed, Inc. · Jul 1994
RH-801/GS MODEL TRANSQ(R)1
K932621 · Iomed, Inc. · Jul 1994
PHORESOR II AUTO, MODEL PM800 MODIFICATION
K934335 · Iomed, Inc. · Jul 1994